KDM4C and breast carcinoma: Here, JMJD2C removes H3K9me3 marks and enhances the binding of HIF-1α leading to enhanced expression of key genes required for breast cancer progression (PDK1) and metastasis to the lung (LOXL2 and L1CAM).